Sonex Health and The Institute of Advanced Ultrasound Guided Procedures announced the publication of study results supporting the role of ultrasound-guided carpal tunnel release (UGCTR) for treating carpal tunnel syndrome (CTS).
The review summarizes the evidence supporting the role of ultrasound in the diagnosis and management of CTS, including the use of ultrasound to assist in diagnosing CTS, perform ultrasound-guided injections, and treat patients with UGCTR.
The authors concluded that ultrasound offers significant advantages in terms of patient comfort, safety, and resource utilization, and is supported by evidence demonstrating diagnostic accuracy comparable to that of electrodiagnostic studies, improved injection safety and efficacy, and surgical outcomes that match or exceed those of conventional CTR surgical approaches.
Sonex Health’s UltraGuideCTR is a single-use, hand-held device indicated for the treatment of carpal tunnel syndrome.
Sonex Health Chief Medical Officer and Co-Founder, Dr. Jay Smith, said, “This independent publication complements a robust and growing number of peer-reviewed studies that report the benefits of UGCTR in more than 2,300 patients and 2,800 hands. Collectively, these publications support the use of UGCTR with balloon dilation as a favorable, minimally invasive surgical option for treating patients suffering from CTS.”
Sonex Health and The Institute of Advanced Ultrasound Guided Procedures announced the publication of study results supporting the role of ultrasound-guided carpal tunnel release (UGCTR) for treating carpal tunnel syndrome (CTS).
The review summarizes the evidence supporting the role of ultrasound in the diagnosis and management of CTS,...
Sonex Health and The Institute of Advanced Ultrasound Guided Procedures announced the publication of study results supporting the role of ultrasound-guided carpal tunnel release (UGCTR) for treating carpal tunnel syndrome (CTS).
The review summarizes the evidence supporting the role of ultrasound in the diagnosis and management of CTS, including the use of ultrasound to assist in diagnosing CTS, perform ultrasound-guided injections, and treat patients with UGCTR.
The authors concluded that ultrasound offers significant advantages in terms of patient comfort, safety, and resource utilization, and is supported by evidence demonstrating diagnostic accuracy comparable to that of electrodiagnostic studies, improved injection safety and efficacy, and surgical outcomes that match or exceed those of conventional CTR surgical approaches.
Sonex Health’s UltraGuideCTR is a single-use, hand-held device indicated for the treatment of carpal tunnel syndrome.
Sonex Health Chief Medical Officer and Co-Founder, Dr. Jay Smith, said, “This independent publication complements a robust and growing number of peer-reviewed studies that report the benefits of UGCTR in more than 2,300 patients and 2,800 hands. Collectively, these publications support the use of UGCTR with balloon dilation as a favorable, minimally invasive surgical option for treating patients suffering from CTS.”
Copy to clipboard 
